Beyfortus 50 mg/0.5 mL single-dose pre-filled syringe Images
Generic Name: nirsevimab
This medication has been identified as Beyfortus 50 mg/0.5 mL single-dose pre-filled syringe. It is supplied by AstraZeneca.
Beyfortus is used in the treatment of RSV Vaccination and Immunization; RSV and belongs to the drug class antiviral monoclonal antibodies. Beyfortus 50 mg/0.5 mL single-dose pre-filled syringe is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Beyfortus
- Generic Name
- nirsevimab
- Strength
- 50 mg/0.5 mL single-dose pre-filled syringe
- Availability
- Prescription only
- Drug Class
- Antiviral monoclonal antibodies
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AstraZeneca
- National Drug Code (NDC)
- 49281-0575
See also:
Arexvy
Arexvy is an RSV vaccine used to prevent severe Respiratory Syncytial Virus Vaccine (RSV) symptoms ...
Abrysvo
Abrysvo vaccine protects against LRTD (lower respiratory tract disease) caused by the Respiratory ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Synagis
Synagis is used to prevent lung disease caused by respiratory syncytial virus. Learn about side ...
mRESVIA
mResvia is an RSV vaccine that may be used to protect adults aged 60 years and older against lower ...
Rebetol
Rebetol is used with interferon alfa to treat chronic hepatitis C. Learn about side effects ...
Ribasphere
Ribasphere is used in combination with interferon to treat patients with chronic hepatitis C ...
More about Beyfortus (nirsevimab)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antiviral monoclonal antibodies
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.